Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer, with approximately 50% of patients having residual disease after neoadjuvant chemotherapy (NACT) and worse prognosis wit
1P-values by Fisher's exact test for dichotomous variables and Wilcoxon Rank Sum Test for continuous variables. 2Participants could have mulitiple opportunistic infections (OIs) so percents do not sum
